受强制性开放获取政策约束的文章 - Subarno Paul了解详情
无法在其他位置公开访问的文章：9 篇
Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
R Pradhan, S Paul, B Das, S Sinha, SR Dash, M Mandal, CN Kundu
The Journal of Nutritional Biochemistry 113, 109257, 2023
强制性开放获取政策： Department of Science & Technology, India
NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells
SR Dash, S Chatterjee, S Sinha, B Das, S Paul, R Pradhan, C Sethy, ...
Nanomedicine: Nanotechnology, Biology and Medicine 40, 102502, 2022
强制性开放获取政策： Department of Science & Technology, India
Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors
S Paul, S Sinha, CN Kundu
Pharmacological Research 184, 106425, 2022
强制性开放获取政策： Department of Biotechnology, India
Exploration of Benzo [b] carbazole-6, 11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effects
S Sisodiya, S Paul, H Chaudhary, P Grewal, G Kumar, DP Daniel, B Das, ...
Bioorganic & Medicinal Chemistry Letters 49, 128274, 2021
强制性开放获取政策： Department of Science & Technology, India
Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through …
R Pradhan, S Paul, SS Acharya, S Sinha, SR Dash, CN Kundu
The Journal of Nutritional Biochemistry 125, 109568, 2024
强制性开放获取政策： Department of Science & Technology, India
Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β
SR Dash, B Das, C Das, S Sinha, S Paul, R Pradhan, CN Kundu
Nanomedicine 18 (1), 19-33, 2023
强制性开放获取政策： Department of Science & Technology, India
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
S Paul, S Chatterjee, S Sinha, SR Dash, R Pradhan, B Das, K Goutam, ...
Expert Opinion on Therapeutic Targets 27 (10), 999-1015, 2023
强制性开放获取政策： Department of Biotechnology, India
Design, synthesis, and anticancer activity of some novel 1H-benzo [d] imidazole-5-carboxamide derivatives as fatty acid synthase inhibitors
S Singh, S Paul, NF Brás, CN Kundu, C Karthikeyan, NSHN Moorthy
Bioorganic Chemistry 138, 106658, 2023
强制性开放获取政策： Department of Science & Technology, India, Fundação para a Ciência e a …
Near infrared-responsive quinacrine–gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells
SR Dash, C Das, B Das, AB Jena, S Paul, S Sinha, J Tripathy, CN Kundu
Nanomedicine 19 (7), 581-596, 2024
强制性开放获取政策： Department of Science & Technology, India
可在其他位置公开访问的文章：2 篇
Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents
VK Rao, S Paul, M Gulkis, Z Shen, H Nair, A Singh, C Li, AK Sharma, ...
RSC Medicinal Chemistry 15 (3), 937-962, 2024
强制性开放获取政策： Council of Scientific and Industrial Research, India, Department of …
Design, synthesis and biological evaluation of Novel 1H-benzo [d] imidazole derivatives as Fatty Acid Synthase (FASN) inhibitors for cancer treatment
S Singh, S Paul, C Karthikeyan, NF Brás, CN Kundu, NSHN Moorthy
Medical Sciences Forum 14 (1), 117, 2022
强制性开放获取政策： Department of Science & Technology, India, Fundação para a Ciência e a …
出版信息和资助信息由计算机程序自动确定